Clinical management of anti-tuberculosis related cutaneous adverse drug reactions based on reintroduction

J Travel Med. 2023 Dec 28;30(8):taad134. doi: 10.1093/jtm/taad134.

Authors

Quentin Beytout¹, Nagisa Godefroy¹, Gentiane Monsel¹, Stéphane Jaureguiberry¹, Eric Caumes^{1

2}

Affiliations

¹ Department of Infectious and Tropical Diseases, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
² Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Sorbonne University, INSERM, Paris, France.

PMID: 37831914
DOI: 10.1093/jtm/taad134

No abstract available

Keywords: Anti-tuberculosis treatment cutaneous adverse reaction; cutaneous adverse drug reaction management.

MeSH terms

Antitubercular Agents / adverse effects
Drug-Related Side Effects and Adverse Reactions* / drug therapy
Humans
Tuberculosis* / drug therapy

Substances

Antitubercular Agents